Skip to main content
. 2019 Dec 16;12:28–34. doi: 10.1016/j.ijpddr.2019.12.002

Fig. 3.

Fig. 3

Results from the second simulation study implementing selective therapy at various treatment thresholds and the effect on the rate of MOX resistance development. Treatments administered were either a combination of MOX and BZ (50% efficacy) as in the field study, or MOX single active.